3American College of Reheumatology Subcommittee on Rheumatoid Arthritis Guidelines.Guidelines for the management of ruhematoid arthritis.Arthrisrheum,2002,46:328-326.
4Leies RJ,Derese I,Debaric T,et al.In vitro growith rate of fibroblast-like synovial cells reduced by methotrexate treatment.Ann Rheum Dis.2003,62:568-571.
5Gravallese EM,Manning C,Tsay A,et al.Synovialtissuein-rheumatoid arthritis is a source of osteoclast differentiation factor.Arthritis Rheum,2000,43:250-258.
7Cough A,Sambrook P,Devlin J,et al.Osteoclasticastivationis the principal mechanism Leading to secondary osteoposis in rheumatoid arthristis.Rhematol,1998,25:1282-1289.
8Kermanceh S,Solalm C,Bessis N,et al.Role for osteopotegerin in rheumatoid inflammation.Joint Bone Spine,2004,71:9-13.
9Saidenberg KN,Corrado T,Lemeiter D.TNF-a antibodies and osteoprotegerin decerase systemic bone loss associated with inflammarion though diatanct mechanisms in collagen-induced arthritis.Bone,2004,35:1200-1207.
10Gravallese EM.Bone destruction in arthritis.Ann Rheum DIs,2002,61:84-86.
